Dr. Robison Chan, MD

Dr. Chan practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Chan's NPI, 1144204397, was assigned on December 1, 2005. Dr. Chan graduated from Lewis Katz School of Medicine in 2000. Dr. Chan holds Illinois license 036.138574.

Dr. Chan's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Chan's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Chan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chan's licenses on file in 5 states: Illinois, New York, California, Massachusetts and Pennsylvania.

Dmand AI lists age-related macular degeneration, retinal occlusion, surgical retina and vitreous procedures, visual impairment and blindness and vitreous eye degeneration among the conditions Dr. Chan treats.

CMS data shows 369 Medicare services from Dr. Chan across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $15,243 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Chan in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 71, with 57% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chan for performance year 2024, reported as part of a group. Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 148 papers to Dr. Chan, published from 2009 to 2023. 2020 was the busiest year, with 13. The most frequent topics are Retinopathy of Prematurity, Gestational Age and Ophthalmology. Dr. Chan has published most often in Retina. Dr. Chan's most frequent co-authors are Michael F. Chiang, MD, John Peter Campbell, MD, MPH and Mrinali Patel Gupta, MD.

CMS Open Payments shows 136 general payments to Dr. Chan from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Alcon Laboratories Inc paid the most, $106,192.

Dmand AI lists 15 awards for Dr. Chan, most recently Top Doctor (Ophthalmology) in 2024.

Dr. Chan graduated from Lewis Katz School of Medicine in 2000. Dr. Chan is a member of AAO, AAP, American Association of Pediatric Ophthalmology and Strabismus and ACS.

Dr. Chan is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.